- Issuer ticker
-
AURX
- Reported as of
-
31 Dec 2019
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
5
- Accepted by SEC
-
26 Apr 2022, 21:21:36 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Charles E. Sheedy
Filing notes and source
Key filing fact
Charles E. Sheedy filed Form 5 for Nuo Therapeutics, Inc. (AURX) on 26 Apr 2022.
Key facts
- This page summarizes Charles E. Sheedy's Form 5 filing for Nuo Therapeutics, Inc. (AURX).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Apr 2022, 21:21.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 5 disclosures.
View source filing
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AURX
transaction
Derivative
Warrants to purchase Common Stock
Purchase
- Transaction value
- $0
- Shares
- +15,000
- Change %
- Price
-
$0.000000
- Shares after
- 15,000
- Date
- 15 Nov 2019
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $0.4000
- Footnotes
- F1
AURX
transaction
Derivative
Warrants to purchase Common Stock
Purchase
- Transaction value
- $0
- Shares
- +150,000
- Change %
- +1000%
- Price
-
$0.000000
- Shares after
- 165,000
- Date
- 06 Dec 2019
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $0.4000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote